GABRA4 and prostate carcinoma: Interestingly, the 3′ UTR mutation in the GABA neurotransmitter receptor subunit GABRA4 is the only mutation to have opposite effects in the two cell lines, substantiating the idea that there may be differences in 3′ UTR-mediated regulation of distinct neuronal genes in advanced prostate cancer cells.